The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results